Blog Posts

Big Pharma Watch: Drug Makers Tone Deaf on Crisis of Affordability

Aug 22, 2019

BIO CEO Says Prescription Drugs Are Not Too Expensive If you needed any more Read More

Second Opinion: GAO Undermines Common Refrain in Big Pharma’s Blame Game

Aug 16, 2019

Analysis Finds PBMs Pass On Over 99 Percent of Rebates, Used to Keep Premiums Read More

Q2 Earnings: Big Pharma Keeps Living the Good Life While Evading Accountability

Jul 31, 2019

Q2 Earnings: Big Pharma Keeps Living the Good Life While Evading Read More

Big Pharma Earnings Watch: Amgen, Eli Lilly, Merck and Pfizer

Jul 31, 2019

Four More Rx Giants Complete the Sweep, Beat Q2 Earnings Forecasts After Read More

Big Pharma Earnings Watch: AbbVie and Sanofi

Jul 30, 2019

Brand Name Drug Makers Continue to Surpass Q2 Forecasts After Hiking Prices Read More

Big Pharma Earnings Watch: Bristol-Myers Squibb, AstraZeneca, Roche

Jul 29, 2019

Three More Drug Makers Top Earnings Expectations in Q2   Today three more Read More

Big Pharma Earnings Watch: GlaxoSmithKline

Jul 24, 2019

Big Pharma Giants Now Three for Three Besting Forecasts After Hiking Prices Read More

Second Opinion: Correcting Big Pharma’s Claims On The Rebate Rule

Jul 12, 2019

America’s seniors and taxpayers received a huge win today when the Read More

THEY SAID IT! Senators on Aging Panel Pledge Bipartisan Action To Lower Drug Prices & Hold Big Pharma Accountable

Jun 20, 2019

Washington, D.C. – The U.S. Senate Special Committee on Aging held its third Read More

THEY SAID IT! E&C Lawmakers Pledge Bipartisan Action To Boost Transparency, Hold Big Pharma Accountable & Lower Drug Prices

May 22, 2019

Washington, D.C. – The U.S. House Energy & Commerce Subcommittee on Read More

“Dose of Reality” Breaking Down the Big Pharma Dollar

May 18, 2019

Part IV:  Big Pharma’s Tax Conundrum The average American spends $1 Read More

“Dose of Reality” Breaking Down the Big Pharma Dollar

May 17, 2019

Part III:  As Prices Rise, So Too Does Ad Spending The average American Read More